Naphthyl ketone inhibitors of cholesterol esterase and their use as hypolipidemic and hypocaloric agents

Daniel M Quinn; Gialih H Lin

Back

Naphthyl ketone inhibitors of cholesterol esterase and their use as hypolipidemic and hypocaloric agents

Patent

Open access

Naphthyl ketone inhibitors of cholesterol esterase and their use as hypolipidemic and hypocaloric agents

Daniel M Quinn and Gialih H Lin

United States Patent and Trademark Office

03/03/1992

Files and links (1)

pdf

Naphthyl ketone inhibitors of cholesterol esterase and their use247.18 kBDownload View

PDM V1.0, Open Access

Abstract

Certain 2-naphthyl ketones are used as inhibitors of cholesterol esterase and function as hypolipidemic and hypocaloric agents. The invention also relates to a method of decreasing the absorption of dietary cholesterol and fats through the wall of the intestinal tract.

Details

Title: Subtitle: Naphthyl ketone inhibitors of cholesterol esterase and their use as hypolipidemic and hypocaloric agents
Creators: Daniel M Quinn (Inventor)
Gialih H Lin (Inventor)
Contributors: University of Iowa Research Foundation (Iowa City, IA, US) (Assignee)
Resource Type: Patent
Publisher: United States Patent and Trademark Office; United States
Patent: US Patent 5,093,371; United States Patent and Trademark Office (United States, Alexandria) - USPTO; Published; 07/546,910; 07/02/1990
Number of pages: 8 pages
Language: English
Date published: 03/03/1992
Academic Unit: UI Research Foundation; Chemistry
Record Identifier: 9983762091702771

Metrics

18 File views/ downloads

19 Record Views